期刊文献+

盆底肌电刺激治疗膀胱过度活动症20例分析 被引量:3

Analysis of pelvic floor electrical stimulation and tolterodine in treatment for 20 patients with overactive bladder
下载PDF
导出
摘要 目的 观察盆底肌电刺激治疗膀胱过度活动症(overactive bladder,简称OAB)的疗效。方法 将经临床症状及尿动力学检查确诊的OAB 40例随机分为电刺激治疗组(20例)及药物治疗组(20例)。电刺激治疗组采用盆腔生物反馈电刺激治疗仪,通过阴道或直肠电极对患者进行阴道或直肠内8~70mA的电刺激治疗10~20次;药物治疗组给予舍尼亭(酒石酸托特罗定片)每次2mg口服,每天2次,共服2周。通过排尿日记、副作用及满意度调查表评价疗效。结果 电刺激治疗组治愈率60%,总有效率85%;药物治疗组治愈率50%,总有效率80%。两组疗效及满意率经Ridit分析无显著性差异(P>0.05);两组治疗副作用比较均有显著性差异(P<0.05)。结论盆底肌电刺激能有效治疗OAB,长期疗效仍需进一步观察研究。 Objective To observe the efficacy of electrical stimulation in treating overactive bladder. Methods 40 patients with OAB were randomly divided into 2 groups. Electrical stimulation group (n = 20) used an instrument for electrical stimulation through a special vagina or rectum probe transfer current (8~70mA), 20 min·qd for 10~20 times. Medical group (n = 20) received oral tolterodine 2 mg·bid for 2 weeks. Results The total effective rate and cure rate (85% and 60%, 80% and 50%, respectively) had no significance difference between 2 groups (Ridit's analysis: P>0. 05). Patients satisfactory rate was increased more significantly in electrical stimulation group than in medical group (P<0. 05). Side effects were commoner with tolterodine. Conclusion Electrical stimulation is effective and safe for overactive bladder. Further study is necessary to show the long--term efficacy and cost analyses of electrical stimulation.
出处 《福建医药杂志》 CAS 2004年第1期6-8,共3页 Fujian Medical Journal
关键词 盆底肌电刺激 治疗 膀胱过度活动症 药物疗法 物理疗法 逼尿肌不稳定 尿失禁 Electrical stimulation Detrusor instability Urinary incontinence
  • 相关文献

参考文献2

二级参考文献1

共引文献164

同被引文献18

  • 1虎华静,吴建军,庞键.盆底肌电刺激治疗前列腺术后逼尿肌不稳定20例[J].四川医学,2005,26(8):856-858. 被引量:3
  • 2蔡丹,王涛,刘继红,杜广辉,陈忠,杨为民,叶章群.盆底生物反馈治疗前列腺术后尿失禁[J].中国康复,2005,20(4):232-233. 被引量:19
  • 3那彦群,孙光主编.中国泌尿外科疾病诊断和治疗指南(2011版)[M].北京:人民卫生出版社,2011:103-119,135—140.
  • 4AZADZOI K M, TARCAN T, SIROKY M B, et al. Atherosclerosis-induced cluxuic ischemia causes blad- der fibrosis and non-compliance in the rabbit[J]. J Urol, 1999,161(5) :1626-1635.
  • 5那彦群,孙光.中国泌尿外科疾病诊断和治疗指南手册.北京:人民卫生出版社,2011:163-212,223-227.
  • 6Barry M J, Fowler FJ, Leary MP, et al. The American urological associa- tion symptom index for benign prostatic hyperplasia. The measurement committee of the American urological. J Urol, 1992,148 : 1549-1557.
  • 7Homma Y, Yosshida M, Seki N, et al. Symptom assessment tool for over active bladder syndrome-overactive bladder symptom score. Urology, 2006,68:318-323.
  • 8Knutson T, Edlund C, Fall M, et al. BPH with coexisting overactive bladder dysfunction.-an everyday urological dilemma. Neurourol Uro- dyn,2001,20 :237-247.
  • 9Chiaffarino F. Parazzini F, Lavezzari M, et al. Impact of urinary inconti- nence and overactive bladder on quality of life. Eur Urol, 2003,43: 535 -538.
  • 10Seki N,Yuki K, Takei M, et al. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Neurourol Urodyn, 2009,28:197- 201.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部